Supply chain problems for Chagas disease treatment

The Lancet Infectious Diseases

Volumn 12, Issue 3, 2012, Pages 173-175

  Manne, Jennifer ^a   Snively, Callae S ^a   Levy, Michael Z ^b   Reich, Michael R ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; NIFURTIMOX;

CHAGAS DISEASE; DRUG INDUSTRY; DRUG MANUFACTURE; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH PROGRAM; HUMAN; LETTER; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; WORLD HEALTH ORGANIZATION;

CHAGAS DISEASE; HUMANS; NIFURTIMOX; NITROIMIDAZOLES; TRYPANOCIDAL AGENTS;

EID: 84857171534     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70001-4     Document Type: Letter

References (12)

1. Burki T Production of drugs for Chagas disease predicted to fall short. Lancet Infect Dis 2011, 11:901-902.
2. Bayer extends support to fight Chagas Disease Bayer Healthcare, (accessed Nov 11, 2011). http://www.press.bayer.com/baynews/baynews.nsf/id/Bayer-extends-support-to-fight-Chagas-disease.
3. Jannin J, Villa L An overview of Chagas disease treatment. Mem Inst Oswaldo Cruz 2007, 102(suppl 1):95-97.
4. The shortage of benznidazole leaves thousands of chagas patients without treatment Médecins Sans Frontières, (accessed Oct 20, 2011). http://doctorswithoutborders.com/press/release.cfm?id=5547&cat=press-release.
5. Baker BK, Ombaka E The danger of in-kind drug donations to the Global Fund. Lancet 2009, 373:1218-1221.
6. Progress reports: report by the secretariat (EB130/35 Add.3) World Health Organization, (accessed Feb 3, 2012). http://apps.who.int/gb/ebwha/pdf_files/EB130/B130_35Add3-en.pdf.
7. Lescure FX, Le Loup G, Freilij H, et al. Chagas disease: changes in knowledge and management. Lancet Infect Dis 2010, 10:556-570.
8. Yun O, Lima MA, Ellman T, et al. Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières. PLoS Negl Trop Dis 2009, 3:e488.
9. Frost LJ, Reich MR Access: how do good health technologies get to poor people in poor countries 2008, Harvard Center for Population and Development Studies, Cambridge, USA.
10. Global Alliance to Eliminate Lymphatic Filariasis, (accessed Jan 30, 2012). http://www.filariasis.org/.
11. Call to action for Latin America to boost innovation and access for neglected disease patients in the region: 6 actions for 2012 and beyond Drugs for Neglected Diseases initiative, (accessed Jan 30, 2012). http://www.dndi.org/global/call-to-action.html.
12. Uniting to Combat Neglected Tropical Diseases: Ending the neglect and reaching 2020 goals (accessed Jan 30, 2012). http://www.unitingtocombatntds.org/.